Severe Asthma Network Italy
NCT06625216 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 5000
Last updated 2026-04-29
Summary
The goal of this registry is collecting data of severe asthma patients, recruited by specialized centers, in a real life setting, homogeneously placed on a database management system to follow them over the time.
The information recorded will provide:
1. The collection of homogeneous clinical, functional and biologic data of patients with severe asthma in a real life setting.
2. The evaluation of adherence to treatment in real life.
3. The clinical eligibility of patients treated with biologics.
4. The evaluation of patients' clinical response to each treatment.
5. The monitoring of tolerability and safety.
6. The long-term follow up of patients with severe asthma.
Conditions
Sponsors & Collaborators
-
Societa Italiana di Pneumologia
collaborator OTHER -
Società Italiana di Allergologia, Asma e Immunologia Clinica
lead OTHER
Principal Investigators
-
Enrico Marco Heffler, MD, PhD · Personalized Medicine, Asthma and Allergy - IRCCS Humanitas Research Hospital, Rozzano, Italy
Eligibility
- Min Age
- 13 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-02-17
- Primary Completion
- 2027-02-17
- Completion
- 2037-02-17
Countries
- Italy
Study Locations
More Related Trials
-
Russian Severe Asthma Registry
NCT03608566 ·Status: UNKNOWN
-
The Study About the Identification of Treatable Traits of Severe Asthma and the Construction of Personalized Treatment System
NCT07136025 ·Status: RECRUITING ·Phase: NA
-
Swiss Severe Asthma Register
NCT03984253 ·Status: RECRUITING
-
Longitudinal Observational Study of Severe Asthma
NCT01780142 ·Status: COMPLETED
-
Observational and Epidemiologic Study of the Disease Course and Unmet Needs in Children With Symptomatic Moderate to Severe Allergic Asthma
NCT01362621 ·Status: COMPLETED
-
Taiwan Severe Asthma Biologic Registry
NCT06456450 ·Status: RECRUITING
-
ChAracterisation of ItaliaN Severe Uncontrolled Asthmatic patieNts Key Features When Receiving Benralizumab
NCT04272463 ·Status: COMPLETED
-
Research on Severe Asthma
NCT04077528 ·Status: RECRUITING
-
Immune Interactions in Severe Asthma
NCT02566668 ·Status: COMPLETED
-
Longitudinal Cohort Study in Participants With Severe Asthma to Assess Biomarkers
NCT02537691 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Characteristics of Severe Childhood Asthma
NCT06024902 ·Status: COMPLETED
-
Portuguese Severe Asthma Registry: Getting Answers for Severe Asthma Patients
NCT04714567 ·Status: UNKNOWN
-
Defining the Severe Paediatric Asthma Endotype
NCT04680117 ·Status: COMPLETED ·Phase: NA
-
Subjective Sleep Quality and Sleep Disorders in Patients With Severe Asthma
NCT04340583 ·Status: TERMINATED
-
Characteristics of Type 2- High Inflammatory Endotype of Asthma Using New Biomarkers From Peripheral Blood and Exhaled Air and Its Effect on the Outcome of Therapy
NCT05270278 ·Status: COMPLETED
-
Longitudinal Phenotyping and Endotyping Study in Adult Patients With Mild, Moderate, or Severe Asthma
NCT07189806 ·Status: RECRUITING
-
Prospective Study on Asthma Control
NCT01110460 ·Status: COMPLETED
-
Cohort Analysis of Clinical and Biological Severe Childhood Asthma
NCT02114034 ·Status: ACTIVE_NOT_RECRUITING
-
An Observational, Prospective, Multicenter Study to Evaluate the Biologic Use and Outcomes in Chinese Asthma Patients
NCT06605885 ·Status: ACTIVE_NOT_RECRUITING
-
Study on Patterns of Care in Mild Asthmatic Patients
NCT04598555 ·Status: COMPLETED
-
Identification of Asthma Phenotypes in Severe Asthmatics
NCT01623089 ·Status: RECRUITING
-
Registry of Asthma Characterization and Recruitment 3 (RACR3)
NCT05272241 ·Status: RECRUITING
-
Similarities and Differences of Biological Therapies for Severe Asthma.
NCT04665141 ·Status: UNKNOWN
-
A Translational Study to Describe Clinical Characteristics, Biomarkers and to Identify Phenotypes and Endotypes Associated With Differential Outcomes in Chinese Population
NCT06419413 ·Status: RECRUITING
-
A Real-life Observational Study in Severe Eosinophilic Asthma Adult Participant Treated With Benralizumab in Italy
NCT07214753 ·Status: RECRUITING